Citations

Mayo Clinic

Clear

88160 citation(s) found for "NA".

Integrating Spatial-Temporal Channel Reliability with AI for Robust High-Frequency Oscillation Detection in Intracranial EEG*
Besheli, Behrang Fazli , Ayyoubi, Amir Hossein , Swamy, Chandra Prakash , Mohan, Bobby, Miller, Kai J., Parker, Jonathan J., Worrell, Gregory A., Ince, Nuri F., Miller, Kai J., Worrell, Gregory A. , Ince, Nuri F.

2025 12th International IEEE/EMBS Conference on Neural Engineering (NER) | July 9, 2026 | Volume: No volume available | Issue: No issue available | Pages: 511-516

10.1109/ner61569.2025.11588994 | PMID 42677172 Get It

Data-Driven Hyperparameter Tuning of High-Frequency Oscillation Detection for Seizure-Onset Zone Localization
Hrtonová, Valentina , Kolajová, Martina , Besheli, Behrang Fazli , Ayyoubi, Amir Hossein , Okkabaz, Jhan L., Swamy, Chandra Prakash , Miller, Kai J., Worrell, Gregory A., Ince, Nuri F., Worrell, Gregory A. , Ince, Nuri F.

2025 12th International IEEE/EMBS Conference on Neural Engineering (NER) | July 9, 2026 | Volume: No volume available | Issue: No issue available | Pages: 64-69

10.1109/ner61569.2025.11588923 | PMID 42626223 Get It

Integration and Long-Term Use of the CorTec-BCI2000 Platform in an In Vivo Canine Model
Lampert, F. , Ayyoubi, Amir Hossein , Besheli, Behrang Fazli , Engelhardt, William , Kim, Inyong , Ince, Nuri F., Brunner, Peter, Worrell, Gregory A., Miller, Kai, Mívalt, Filip , Jensen, Michael A. , Ince, Nuri F. , Brunner, Peter , Worrell, Gregory A. , Miller, Kai J.

2025 12th International IEEE/EMBS Conference on Neural Engineering (NER) | July 9, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-6

10.1109/ner61569.2025.11588913 Get It

Novel Compounds as Orexin 2 Receptor Agonists for Treating Narcolepsy
Sabnis, Ram W. , Sabnis, Anika R.

ACS Medicinal Chemistry Letters | July 9, 2026 | Volume: 17 | Issue: 8 | Pages: 1699-1700

10.1021/acsmedchemlett.6c00342 | PMID 42621486 Get It

Abstract Provided herein are novel compounds as orexin 2 receptor agonists, pharmaceutical compositions, use of such compounds in treating narcolepsy, and processes for preparing such compounds.
Programmed cell death ligand 1 (PD-L1) inhibition in tumor naïve mice is bone-sparing throughout the lifespan
Searcy, Madeline B, Joseph, Gwenyth J., Kane, Jeremy, Challa, Laasya, Uppuganti, Sasidhar , Smith, Jailyn A., Harrison, David G. , Weivoda, Megan , Uppuganti, Sasidhar , Harrison, D G , Weivoda, Megan M, Johnson, Rachelle W , Tanaka, Hidenori , Rosenthal, Eben L. , Nyman, Jeffry S. , Johnson, Rachelle W.

Journal of Bone and Mineral Research | July 9, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/jbmr/zjag104 | PMID 42424413 Get It

Abstract Immune checkpoint inhibitors (ICIs) which target immune checkpoint proteins like programmed cell death protein 1 (PD-1) and programmed cell death ligand 1 (PD-L1) have revolutionized cancer therapy. Skeletal toxicities are emerging immune-related adverse events for patients treated with ICIs, and PD-1 blockade in pre-clinical mouse models significantly reduces bone mass. However, the effect of PD-L1 inhibition on the bone throughout development is not well understood. We investigated the role of PD-L1 loss on bone microarchitecture with genetic PD-L1 knockout in myeloid cells using LysM-Cre;PD-L1Flox/Flox mice and pharmacologic inhibition with a PD-L1 neutralizing antibody in adult and aged mice. We report that neither PD-L1 deletion in myeloid cells nor inhibition with α-PD-L1 significantly impacts femoral trabecular bone microarchitecture; however, α-PD-L1 treatment increases vertebral trabecular bone volume. Additionally, PD-L1 blockade influences T cell expansion by decreasing naïve T cells and increasing effector memory T cells in the bone marrow, consistent with previous studies on the effects of PD-1 inhibition. The trabecular bone-sparing effect of PD-L1 inhibition is strikingly different from the bone loss observed with PD-1 blockade. Clinical studies are necessary and justified to determine if PD-L1 may be a less bone destructive alternative for cancer patients treated with ICIs who are at high risk of fracture.
Heterogeneous Treatment Effects in HFpEF: Distinguishing Drug-Specific Response from Prognostic Phenotypes Across Randomized Trials
Santana, Clodomir, Katayama, Asuka, Ballal, Aditya , Liem, David A., Chen, C , Nuno, Miriam, Ebong, Imo, Zhang, Xiao-Dong, Izu, Leighton, Alagna, Laura , Borlaug, Barry A., Butler, Javed, Chirinos, Julio A. , Chutkow, William A., Desai, Akshay S., Desvigne-Nickens, Patrice, Givertz, Michael M., Khan, Sadiya S., Kitzman, Dalane W., Lewis, Gregory D., Redfield, Margaret M., Shah, Sanjiv J., Sharma, Kavita, Taylor, Jennifer , Tinsley, Emily, Wong, Renee, Shah, Sanjiv J., Sirish, Padmini , Liem, David A. , Bidwell, Julie T. , Nuño, Miriam , Ebong, Imo , Izu, Leighton T. , Alagna, Laura, Pesce, Lorenzo L. , Sisk, Ryan K. , Borlaug, Barry A. , Butler, Javed , Desai, Akshay S , Desvigne‐Nickens, Patrice , Givertz, Michael M. , Khan, Sadiya S. , Kitzman, Dalane W. , Lewis, Gregory D. , Rasmussen‐Torvik, Laura J. , Redfield, Margaret M. , Sharma, Kavita , Taylor, Jennifer L., Shah, Sanjiv J , López, Javier E. , Chiamvimonvat, Nipavan , Cadeiras, Martín

No container title available | July 9, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.07.06.26357251 | PMID 42465912 Get It

Abstract Background Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome comprising multiple pathophysiological phenotypes. HFpEF trials have largely enrolled diverse populations and reported average treatment effects, consistently yielding neutral results that may obscure drug-specific benefits within distinct subgroups. To address this issue, we employ an interaction-based that incorporates treatment-by-variable interactions to uncover drug-specific responses. Methods We leveraged four HFpEF clinical trials (TOPCAT, RELAX, NEAT-HFpEF, INDIE-HFpEF) and developed a framework comprising two complementary approaches. The first employed a prognostic responder model to evaluate whether conventional responder definitions reflect treatment-specific benefit or instead capture favorable clinical trajectories common to both treatment and placebo groups. The second used an interaction-based individual treatment effect (ITE) modeling to identify baseline variables that modify therapy effect, distinguishing drug-specific response from prognostic phenotypes. Results Although the prognostic responder model demonstrated good discrimination, further analisys suggested it primarily captured a prognostic signal associated with favorable clinical trajectories common to both treatment and placebo arms. In contrast, the ITE model identified distinct, drug-specific effect modifiers across trials (cardiorenal-inflammatory for spironolactone (TOPCAT), NO-mediated anti-inflammatory for isosorbide mononitrate (NEAT-HFpEF), afterload-reducing for inorganic nitrite (INDIE-HFpEF), and anti–volume-overload for sildenafil (RELAX). Each ITE model demonstrated significance only within its own trial suggesting drug-specific signal. Conclusions The proposed method identifies mechanism-specific effect modifiers, and uncovers clinically meaningful heterogeneity in treatment response, which is not captured by conventional MCID-based approaches. Although exploratory, these findings support phenotype-guided therapy in HFpEF and argue for phenotype-informed trial design to enhance treatment-effect detection and therapy targeting. Graphical Abstract
Vertical Patient Streaming in Emergency Departments
Feizi, Arshya , Orfanoudaki, Agni , Martini, Wayne A , Hodgson, Nicole R. , Saghafian, Soroush , Martini, Wayne A. , Hodgson, Nicole

Management Science | July 9, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1287/mnsc.2024.07517 Get It

Tackling hospital emergency department (ED) overcrowding is a paramount challenge for healthcare systems. To combat this issue, an innovative approach is to identify patients who can be served vertically (i.e., in a seated position) and route them to a dedicated area termed the vertical processing pathway (VPP). Successfully implementing this design requires understanding which patients should be routed to the VPP and when. Currently, the decision to leverage the VPP is made in an ad hoc fashion. To assist our partner hospital and other EDs in capturing the value of the VPP, we develop a machine learning model that provides personalized risk scores predicting whether each arriving patient needs an ED bed. We use these scores as input to a stochastic patient flow model and analytically characterize the optimal VPP policy that minimizes length of stay. We then combine our results to derive an interpretable VPP patient streaming protocol suitable for implementation in practice and conduct a before-and-after experiment in which we leverage empirical analyses to evaluate the impact of integrating it into practice. The implemented protocol led to an 11-minute (4.2%) reduction in ED length of stay in our partner hospital without any adverse effect on quality-of-care outcomes. This effect was statistically significant and remained robust after controlling for various confounding factors and potential sources of endogeneity. Our VPP protocol can also be utilized in other EDs, offering operational improvements without requiring additional resources. This paper was accepted by Stefan Scholtes, healthcare management. Funding: S. Saghafian received financial support from the NSF [Grant CMMI-15 62645], “Data-Driven Management of Post-Transplant Medications,” which partially enabled this work, as well as funding and support from the Harvard Data Science Initiative and the Harvard Mossavar-Rahmani Center for Business and Government. Supplemental Material: The online appendix and data files are available at https://doi.org/10.1287/mnsc.2024.07517 .
Fast Localized Calibration for Spatial‐Spectral Excitation Without Fly‐Back Gradients
Schär, Michael , Ganji, Sandeep , Ganji, Sandeep K , Schär, Michael , Weiss, Robert G., Hays, Allison G

Magnetic Resonance in Medicine | July 9, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/mrm.70508 | PMID 42424098 Get It

ABSTRACT Purpose Standard spatial‐spectral excitation pulses apply a fly‐back gradient between sub‐pulses, limiting, for example, how thin the slices can be (> 4 mm). Without fly‐back gradients, slices can be as thin as 1.7 mm but require a phase calibration for the sub‐pulses with inverted gradients due to system imperfections. Here we propose and test a fast (< 1 s), localized pre‐scan enabling thin‐slice frequency‐selective excitation. Methods The calibration pre‐scan determines the correction phase between even and odd sub‐pulses by measuring the phase difference of two FIDs excited with either the last or second‐to‐last RF sub‐pulse of the spatial‐spectral pulse. Non‐localized and localized versions of the calibration pre‐scan are tested and validated for water‐only excitation in phantoms and the human heart. As an example, breath‐held coronary MR angiography is performed with a spiral multi‐slice sequence employing the proposed pulses with a slice thickness of 1.7 mm. Results The proposed calibration pre‐scan takes 11.1 ms per slice, whether it is localized or not. Localized calibration phases are validated with an image‐based calibration map. Slice profiles are visualized for pulses with different time‐bandwidth products. Fat is suppressed to below 20% and 25% of the surrounding water signal in both phantoms and the human heart, respectively. High‐quality coronary angiograms are demonstrated in all test subjects. Conclusion Spatial‐spectral pulses without fly‐back gradients can be calibrated quickly (up to 90 slices in 1 s), enabling thinner slices, higher excitation angles, or pulses with sharper slice profiles using waveforms with higher time‐bandwidth products.
An Anatomic Study of the Endoscopic Orbitozygomatic Approach for Extradural Access to the Orbit, Cavernous Sinus, and Infratemporal Fossa
Yüncü, Mustafa Eren , Bilgin, Berra , Kartum, Tufan Agah , Ekert, Justyna O. , Middlebrooks, Erik H. , Karadağ, Ali , Tanriover, Necmettin , Middlebrooks, Erik H

Operative Neurosurgery | July 9, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1227/ons.0000000000002130 | PMID 42423602 Get It

BACKGROUND AND OBJECTIVES: Access to the orbit, cavernous sinus, Meckel cave (MC), and infratemporal fossa (ITF) remains challenging due to the complex 3-dimensional anatomy and proximity to critical neurovascular structures. An extradural endoscopic orbitozygomatic (OZ) approach has the potential to provide a direct surgical corridor across these compartments while minimizing the limitations of compartment-specific corridors. METHODS: Five formalin-fixed, silicone-injected cadaveric heads (10 sides) were dissected using an extradural OZ approach under operative microscopy supplemented with 0° and 30° rigid endoscopes. After a two-piece OZ craniotomy, extradural dissection was performed toward the superior orbital fissure and foramen rotundum/ovale, combined with anterior petrosectomy and opening of MC. Anatomic exposure, corridor continuity, and visualization of key neurovascular structures were qualitatively assessed. RESULTS: The extradural endoscopic OZ approach created a direct working corridor from the lateral orbit to the ITF and petroclival region. Endoscopic augmentation enhanced visualization of the lateral cavernous sinus wall, trigeminal divisions (V 1 -V 3 ), cavernous internal carotid artery, medial orbital apex, deep infratemporal recesses, and the petroclival region. Anterior petrosectomy extended exposure toward the upper clivus and ventrolateral brainstem. Limitations included restricted microscopic visualization of the medial orbit and inferior ITF, which were partially mitigated by angled endoscopy. CONCLUSION: This cadaveric study demonstrates that the extradural OZ–anterior petrosectomy approach establishes a continuous anatomic corridor integrating the orbit, cavernous sinus/MC, ITF, and petroclival region, while defining its boundaries, areas of optimal exposure, and inherent limitations. As a qualitative study, the findings are descriptive in nature and do not include quantitative morphometric analysis.
Longitudinal Modeling of Pitching Workload and Countermovement Jump Performance as Determinants of Fastball Velocity and Consistency in Collegiate Baseball Pitchers
Burke, Adam A. , Saine, Noelle D., King, Erica L. , Ja, Fields, Miller, Angela D. , Green, Bowling, Jones, Margaret T. , Jones, Margaret T , Fields, Jennifer B., Jagim, Andrew R.

Journal of Strength & Conditioning Research | July 9, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1519/jsc.0000000000005602 | PMID 42423608 Get It

Abstract Burke, AA, Saine, ND, King, EL, Fields, JB, Jagim, AR, Miller, AD, Green, BC, and Jones, MT. Longitudinal modeling of pitching workload and countermovement jump performance as determinants of fastball velocity and consistency in collegiate baseball pitchers. J Strength Cond Res XX(X): 000–000, 2026—Maintenance of four-seam fastball (FSFB) velocity across the baseball season is critical, yet the extent to which workload and neuromuscular status relate to velocity is unclear. Thus, aims of the current study were to assess the relationship between external pitching workload metrics and FSFB velocity; quantify within-season FSFB velocity; and examine how countermovement jump (CMJ) performance predicts FSFB velocity. Collegiate pitchers ( n = 8) completed weekly CMJ testing during a 15-week, 53-game season. Countermovement jump metrics included jump height (JH), reactive strength index–modified (RSImod), peak braking force, and peak propulsive force normalized to body mass. Workload variables (innings, total pitches, FSFB pitches) and FSFB velocity were evaluated via repeated measures correlation (RMCORR). A longitudinal heat map visualized velocity trends, and a hierarchical location–scale model assessed predictors of mean velocity and variance. Repeated measures correlation showed weak negative associations between FSFB velocity and innings ( r = −0.15, p = 0.11), total pitches ( r = −0.18, p = 0.05), and FSFB pitches ( r = −0.18, p = 0.05). Heat map analysis identified 3 distinct velocity clusters. Location model results indicated no predictors of mean velocity. The scale model showed JH ( γ = −0.060, p = 0.001) predicted reduced velocity variance, and RSImod ( γ = 3.800, p < 0.001) predicted increased variance. Findings suggest that velocity patterns varied across athletes, where greater workloads were negatively associated with FSFB pitch velocity. Further, CMJ performance related to velocity stability rather than mean velocity. Routine longitudinal monitoring and continued strength-power training are recommended to support FSFB velocity.